Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.
Clinical trial NCT04932850 · COMPLETED
Trial details
- NCT number
- NCT04932850
- Sponsor
- Toscana Life Sciences Sviluppo s.r.l.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-10-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.